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Ethnic and religious minorities have been disproportionately affected by SARS-CoV-2          
worldwide. The UK strictly-Orthodox Jewish community has been severely affected by the            
pandemic. This group shares characteristics with other ethnic minorities including larger           
family sizes, higher rates of household crowding and relative socioeconomic deprivation. We            
studied a UK strictly-Orthodox Jewish population to understand how COVID-19 had spread            
within this community.  
Methods 
We performed a household-focused cross-sectional SARS-CoV-2 serosurvey specific to         
three antigen targets. Randomly-selected households completed a standardised        
questionnaire and underwent serological testing with a multiplex assay for SARS-CoV-2 IgG            
antibodies. We report clinical illness and testing before the serosurvey, seroprevalence           
stratified by age and gender. We used random-effects models to identify factors associated             
with infection and antibody titres.  
Findings  
A total of 343 households, consisting of 1,759 individuals, were recruited. Serum was             
available for 1,242 participants. The overall seroprevalence for SARS-CoV-2 was 64.3%           
(95% CI 61.6-67.0%). The lowest seroprevalence was 27.6% in children under 5 years and              
rose to 73.8% in secondary school children and 74% in adults. Antibody titres were higher in                
symptomatic individuals and declined over time since reported COVID-19 symptoms, with           
the decline more marked for nucleocapsid titres.  
Interpretation 
In this tight-knit religious minority population in the UK, we report one of the highest               
SARS-CoV-2 seroprevalence levels in the world to date. In the context of this high force of                
infection, all age groups experienced a high burden of infection. Actions to reduce the              
burden of disease in this and other minority populations are urgently required.  
Funding 
This work was jointly funded by UKRI and NIHR [COV0335; MR/V027956/1], a donation             
from the LSHTM Alumni COVID-19 response fund, HDR UK, the MRC and the Wellcome              
Trust. The funders had no role in the design, conduct or analysis of the study or the decision                  
to publish. ​The authors have no financial relationships with any organizations that might             
have an interest in the submitted work in the previous three years; no other relationships or                
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Research In Context 
Evidence before the study 
In January 2020, we searched PubMed for articles on rates of SARS-CoV-2 infection             
amongst ethnic minority groups and amongst the Jewish population. Search teams included            
“COVID-19”, “SARS-CoV-2”, seroprevalence, “ethnic minority”, and “Jewish” with no         
language restrictions. We also searched UK government documents on SARS-CoV-2          
infection amongst minority groups. By January 2020, a large number of authors had reported              
that ethnic minority groups experienced higher numbers of cases and increased           
hospitalisations due to COVID-19. A small number of articles provided evidence that            
strictly-Orthodox Jewish populations had experienced a high rate of SARS-CoV-2 infection           
but extremely limited data was available on overall population level rates of infection             
amongst specific ethnic minority population groups. There was also extremely limited data            
on rates of infection amongst young children from ethnic minority groups.  
Added value of the study 
We report findings from a population representative, household survey of SARS-CoV-2           
infection amongst a UK strictly Orthodox Jewish population. We demonstrate an extremely            
high seroprevalence rate of SARS-CoV-2 in this population which is more than five times the               
estimated seroprevalence nationally and five times the estimated seroprevalence in London.           
In addition the large number of children in our survey, reflective of the underlying population               
structure, allows us to demonstrate that in this setting there is a significant burden of disease                
in all age groups with secondary school aged children having an equivalent seroprevalence             
to adults.  
 
Implications of the available evidence 
Our data provide clear evidence of the markedly disproportionate impact of SARS-CoV-2 in             
minority populations. In this setting infection occurs at high rates across all age groups              
including pre-school, primary school and secondary school-age children. Contextually         
appropriate measures to specifically reduce the impact of SARS-CoV-2 amongst minority           
populations are urgently required. 
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The UK has been severely affected by the COVID-19 pandemic with 66,197 deaths involving              
COVID-19 up to the 27th November 2020 ​1​. In the UK the pandemic has disproportionately              
affected minority ethnic populations with relatively higher numbers of positive cases and            
overrepresentation in admissions to hospitals and Intensive Care Units and deaths.​2–4​.           
Similar disparities have been observed in other settings and amongst hospitalised patients,            
mortality has been found to be higher in ethnic minority patients in both the UK and USA​5–7​.                 
The reasons for this disparity are unclear but are likely multifactorial, reflecting both higher              
rates of infection resulting from socio-economic factors including deprivation, less ability to            
work from home, higher use of public transport and larger household sizes, as well as               
increased severity of illness due to higher rates of comorbidities or delayed access to care ​8​. 
 
Most population based studies in the UK have focused on the impact experienced by larger               
minority ethnic groups and not on smaller groups, such as the Jewish community, despite              
comprising approximately 265,000 individuals or 0.5% of the UK’s population ​9​. In particular,            
strictly Orthodox Jewish communities have anecdotally reported high rates of infection,           
morbidity and hospitalisation during the first wave of the UK pandemic​10​. These anecdotal             
reports are supported by findings from Public Health England (PHE) which suggests a higher              
risk from infection in the UK Jewish population and higher rates of death due to COVID-19 in                 
those self identifying as Jewish with an age standardised mortality rates between March and              
May for Jewish men over 65 years of 759 per 100,000 population, much higher than in other                 
religious groups​11​. This higher rate of infection amongst the Jewish community might reflect             
socio-demographic differences compared to the general UK population. Strictly Orthodox          
Jewish communities have among the highest total fertility rates in the UK, and experience              
high rates of overcrowded homes and higher levels of socio-economic deprivation ​12,13​.            
However, after adjusting for socio-economic factors the hazard ratio for death in Jewish men              
remained double that of Christian men suggesting that routine socio-economic factors alone            
do not explain all of the increased rate of infection seen in this community​11 . During the first                  
wave of the COVID-19 pandemic in Israel, strictly Orthodox Jewish communities also            
reported higher incidence rates of COVID-19 than other socio-economically similar          
communities​14,15​, or when compared to households in Arab communities with similar sizes            
and levels of crowding ​15​. 
 
In Spring 2020, a UK tightly-knit strictly-Orthodox Jewish community became aware that they             
appeared to be experiencing a high burden of SARS-CoV-2. In view of this, and national               
data suggesting a high burden of infection in the Jewish community and a possible              
disproportionately high burden in the strictly Orthodox community, we co-developed a           
cross-sectional serological survey to measure the burden of infection and identify factors            
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Methods 
Recruitment and survey methodology 
Within a strictly Orthodox Jewish community in the UK we conducted a household-focused             
seroprevalence survey between late-October and early December 2020 prior to the third            
national lockdown. We obtained a comprehensive list of all resident households within the             
community, held by our community collaborators, and randomly selected households for the            
study. A second list of households where laboratory confirmed infections were known to             
have occured (the ‘enriched’ list) was also included to inform subsequent transmission            
models. Members of the study team telephoned households to complete a standardised            
questionnaire, including demographics, comorbidities, report of any previous presumed         
COVID-19 illness, previous PCR or serological testing for SARS-CoV-2, access to care            
whilst unwell with a COVID-19 like illness, illness severity, attendance at work, educational             
or other community locations and travel overseas between February - November 2020. All             
households were visited within 10 days of completing the questionnaire, all participants had             
blood drawn for a serum sample except where a member of the household reported active               
symptoms of COVID-19 in which case the visit was scheduled for a minimum of 14 days                




Serum samples were analysed for the presence of IgG specific for SARS CoV-2 trimeric              
spike protein (S), Receptor Binding Domain (RBD) and nucleocapsid (N) antigens using a             
multiplex chemiluminescence immunoassay (MSD, Rockville, MD) evaluated by our         
laboratory as previously described ​16,17​. 
 
Statistical analysis 
Assuming 10% seroprevalence and a design effect of 2 we calculated we would need to               
recruit 1,730 participants. Assuming an average household size of 6 we estimated this would              
be approximately 300 households.  
 
To obtain unbiased estimates, we restricted our analysis to individuals from randomly            
selected households. Results related to the ‘enriched’ household dataset will be presented in             
future analyses. We used cut-off values for the SARS-CoV-2 immunoassay from previous            
validation studies for antibodies against trimeric-spike, nucleocapsid and receptor binding          
domain. For the purpose of this analysis, we considered a positive trimeric-spike response             
as evidence of a prior SARS-CoV-2 infection as this target was shown to be the most                
sensitive and specific target in assay validation ​16​. As assay cut-offs are well defined in adults               
but less well defined in children, we conducted a sensitivity analysis in which we considered               
thresholds for the trimeric-spike assay of twice the previously defined limit.  
 
We report the proportion of individuals who had a clinical illness consistent with COVID-19              
and the proportion of individuals who had accessed testing prior to this survey. We              
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calculated the seroprevalence of SARS-CoV-2 infection stratified by age and gender and            
adjusted for clustering at the household level. Age was classified as pre-school (0-4 years),              
primary education (5-10 years), secondary education (11-18 years), adults and retirement           
(greater than 67 years). We created a proxy variable which accounted for the number of               
community events attended during the year (hereinafter ‘community-gatherings’) and a          
variable reflecting household overcrowding based on the number of household residents and            
the number of bedrooms​18​. To identify factors associated with SARS-CoV-2 infection we            
fitted a multivariable random-effects logistic regression model adjusted for clustering at the            
household level. We hypothesised that age, gender, being unable to work from home,             
attendance at community events and household overcrowding were ​a priori likely to be             
associated with an increased risk of infection. We assessed relationships between titres of             
antibodies against each of SARS-CoV-2 spike, receptor binding domain and nucleocapsid in            
relation to individuals age, gender, the presence or absence of a symptomatic illness, and              




The study was approved by the London School of Hygiene & Tropical Medicine Ethics              
Committee (​Ref 22532​). Verbal informed consent was given during the telephone survey            




Enrollment and demographics 
A total of 903 randomly selected households were approached, of which 343 households             
comprising 1,759 individuals were enrolled (Figure 1). An additional 70 households with            
known cases of COVID-19 were provided by our community partners (referred to as             
‘enriched households’) were approached to participate, of which 28 households comprising           
183 individuals were enrolled (Supplementary Figure 3). Serum samples were collected           
from 1242 individuals (70.6%) from 283 randomly selected households and 137 individuals            
(74.9%) from 24 ‘enriched households.  
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Figure 1. ​ ​CONSORT diagram for recruitment into the study ​. 
 
 
The median household size was 5 (IQR 3-7, Range 1-14 cf. UK median 2)​19 with a median of                  
3 bedrooms (IQR 2-5). The median age of survey participants was 14 years (IQR 7-33, cd.                
UK median age 40 years) and 48.6% of participants were male (Supplementary Table 1). Of               
individuals who gave a serum sample 48% were male and the median age was 16 years                
(IQR 9-37).  
 
 
Routine Testing for SARS-CoV-2 
Amongst randomly selected households, a total of 446 individuals (25.4%) had undertaken            
either PCR or serological testing for SARS-CoV-2 and 182 individuals (10.3%) reported a             
positive result on at least one test. Reported reasons for testing were because of              
symptomatic disease or stated as “for other reasons” (Table 1). Individuals who reported             
testing were older (median 31 IQR 15-46 vs 12 IQR 5-25) and more likely to be male (52.7%                  
vs 47.1%).  
 
Overall 228 individuals (13%) underwent either PCR and/or serological testing because of            
symptomatic illness. A total of 191 symptomatic individuals reported providing a sample for             
PCR with a swab positivity rate of 59% (n = 113). By comparison 20 of 181 PCR tests done                   
for other reasons were positive (11%). Overall 182 individuals (10.3%) reported already            
having received a positive test for SARS-CoV-2 prior to the survey.  
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Table 1. ​ ​Characteristics of the tests undertaken​, stratified by presence of symptoms. 
 
 
Serology on this cohort revealed an overall seroprevalence for SARS-CoV-2 of 64.3% (95%             
CI 61.6-67.0%, 799/1,242). The seroprevalence varied by age between 27.6% (95%           
confidence interval (CI) 20.8 - 35.6%) for children aged under 5 years of age to 73.8% (95%                 
CI 68.2 - 78.8%) amongst secondary school children and 74% (95% CI 70.0 -77.6%) adults               
(Figure 2) (Supplementary Table 2). Seroprevalence was significantly higher amongst men           
(68.8%, 95% CI 64.9 - 72.5%) than women (59.7%, 95% CI 55.8 - 63.5%) (​p = 0.001). Only                  
three individuals (2%) reported a previous positive PCR result but did not have detectable              
anti-spike antibodies. All three individuals had a positive PCR in October and therefore a              
negative serological test might reflect that they had not yet seroconverted at the time of               
sample collection. In a multivariable random-effects logistic regression model, seropositivity          
was associated with increasing age, male gender, household density and being unable to             
work from home, but not associated with attendance at community gatherings (Table 2). No              





Figure 2 ​. ​Age specific seroprevalence in participants in the study. Colours indicate male and              
female participants. 
  
 Tested for any reason Tested due to 
symptomatic illness 
Tested for any other 
reasons 

















Serology 128 (7.3%) 55 (43.0%) 47 (2.7%) 31 (66.0%) 83 (4.7%) 25 (30.1%) 
Total 446 
(25.4%) 
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Table 2. Association between seropositivity and demographic and behavioural variables.          
*Likelihood ratio test 
 
 
Overall, 697 (37.5%) individuals reported an illness they thought was consistent with            
COVID-19. There were clear peaks in reported illness consistent with the first and second              
waves of COVID-19 in the United Kingdom (Figure 3). Of individuals reporting a suspected              
illness 49.8% were male and the median age was 28 (IQR 14-41). A total of 16 (0.9%)                 
individuals reported hospitalisation for COVID-19 and a further three individuals were           
reported to have died of COVID-19.  
 
 
 Unadjusted Odds Ratio Adjusted Odds Ratio 
OR p-value* aOR (95% CI) p-value* 
Age Young Children 
(0-4 years) 
0.07 (0.04 - 0.12) <0.0001 
 
0.10 (0.05-0.20) <0.0001 
Primary Education 
(5-10 Years) 









adults (67+ Years) 
0.32 (0.13-0.80) 0.35 (0.14-0.91) 
 
Gender 
Female 1  
0.009 
1  
0.002 Male 1.46 (1.10 - 1.93) 1.62 (1.18-2.24) 
 
Housing 
Not overcrowded 1  
0.49 
1  






nor in Education 
1 <0.001 1 0.06 
In Education 0.49 (0.35 - 0.67) 0.45 (0.25-0.81) 
Working From 
Home 
1.78 (1.1 -2.87) 1.39 (0.82-2.38) 
Working Outside 
Home 
1.25 (0.68-2.3) 0.81 (0.41-1.58) 
Number of Community 
Gatherings Attended 
1.02 (0.98-1.06) 0.34 1.04 (0.84-1.28) 0.7 
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Figure 3. Self-reported COVID-19-like illness in participants in the study stratified by age and              
antibody status. The reduced number of self-reported cases in November is an artefact reflecting the               
timing of the survey. Missing Anti-Spike antibody status occured when participants did not participate              
in phlebotomy after completing the survey. No phlebotomy samples gave an inconclusive result. 
 
Overall 81.9 % of individuals who reported an illness consistent with COVID-19 were             
sero-positive and 53.7% of asymptomatic individuals were sero-positive. Of cardinal          
symptoms of COVID-19, self-reported cough (OR 3.0, 95% CI: 2.1-4.2), fever (OR 2.3, 95%              
CI: 1.6 -3.4) and loss of smell or taste (OR 11.8, 95% CI: 6.8 -20.6) were all associated with                   
seropositivity. In the overall population self-reported loss of smell or taste had a positive              
predictive value of 94.5% for positive serology (Supplementary Table 3).  
 
Titres of spike, receptor binding domain and nucleocapsid antibodies were higher amongst            
individuals who reported a symptomatic illness (Figure 4) (Table 3). Amongst symptomatic            
individuals titres declined following time since reported symptomatic illness which was more            
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Figure 4. Log normalised antibody titres for anti-Spike, anti-Receptor Binding Domain and            
anti-Nucleocapsid. ​Each panel is stratified by reporting of COVID-19-like symptoms by the            
participant. The shape shows the density of the distribution of samples. 
  
Male Gender 0.057 -0.09 - 
0.206 
0.448 0.061 -0.075 - 
0.198 
0.381 0.033 -0.094 - 
0.160 
0.612 
Age (years) 0.010 0.006 - 
0.014 
<0.0001 0.009 0.005 - 
0.013 











0.041 -0.001 0.000 - 
0.002 
0.022 -0.002 -0.001 - 
-0.003 
<0.0001 
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We found an extremely high seroprevalence of SARS-CoV-2 antibodies in a strictly            
Orthodox Jewish community in the UK. Our estimate of 65% population seroprevalence is             
markedly higher than recent estimates of 6.9% (95%CI 6.3-7.4%) nationally and 10.8% (95%             
CI 9.3-12.5%) in London by random sampling in October by the Office for National Statistics               
(ONS)​20​. Rapid declines in self-reported illness followed the introduction and adherence to            
lockdown in March, demonstrating that even in this highly connected community such            
measures are effective at reducing transmission. However over the course of 2020, the             
overall seroprevalence in this tightly knit religious community reached levels similar to those             
seen in Manaus, Brazil where a seroprevalence of more than 65% has been reported in               
adults​21​. As our survey was completed by early December 2020, prior to the subsequent              
winter case surge in London, it is likely that the overall burden of infection in this community                 
is now even higher.  
 
Our estimates are amongst the highest sero-prevalence of SARS-CoV-2 described          
anywhere in the world to date. The precise reasons why the burden of SARS-CoV-2 has               
been so high in this population are unclear. In Israel, Orthodox Jewish communities had              
markedly higher SARS-CoV-2 PCR swab positive incidence rates compared to other           
socio-economically similar communities during the first wave of the Israeli epidemic​14,15​. Data            
from other sources suggest that lower socio-economic status, ongoing need to travel to work              
and a greater burden of pre-existing comorbidities, may all contribute to increased risk of              
acquiring SARS-CoV-2.  
 
In our study population there was high seroprevalence in all age groups, with the highest               
seroprevalence in working-age adults and older children where seroprevalence reached          
74%. A strength of our study is the extremely high number of children recruited, which               
reflects the high total fertility rates amongst strictly Orthodox Jewish women ​12,13​.           
Seroprevalence in the youngest children was lower at 27% but rose rapidly to more than               
50% amongst primary school-aged children. The seroprevalence found in this group is            
approximately four times that reported in a UK multicentre study on healthcare worker             
children aged 2-15 years demonstrating the high rates of infection in all age groups in the                
current study ​22​.  
 
Seroprevalence was higher amongst men than women in our study. Higher SARS-CoV-2            
attack rates in men compared to women have also been reported in other contexts​23​. The               
higher rate of infection amongst men might reflect biological differences, differences in            
comorbidities, differences in social mixing patterns or other behaviours. We did not find any              
significant associations with reported attendance at community events, workplace or          
household overcrowding in this population which may be because of a true absence of              
effect, or that due to the extremely high seroprevalence, the ability to detect risk factors is                
limited.  
 
The majority of reported symptomatic illness occurred during the first and second waves of              
the COVID-19 pandemic mirroring case reporting patterns seen across London and the UK.             
Just over 10% of participants reported at least one swab test due to symptomatic illness               
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since March, with an overall swab positivity rate of 59%. In line with other studies, children                
were significantly less likely to report a symptomatic illness​24,25​.  
 
We found that antibody titres against spike and nucleocapsid proteins declined at different             
rates, and in line with other studies​16,26​, that anti-nucleocapsid declined more quickly. If we              
had used only anti-nucleocapsid antibodies as a marker of previous infection our estimated             
seroprevalence would have been 42.8%, significantly under-estimating the likely size of the            
epidemic that has occurred in this population. Declines in anti-spike antibody titre were less              
marked over time but it is still possible that we have under-estimated the true              
seroprevalence in this population. Titres of both spike and nucleocapsid antibodies were            
higher amongst individuals who reported symptomatic illness. 
 
Our study has a number of limitations. We recruited 38% of households that were              
approached and obtained serum samples from 70% of study participants. This enrollment            
rate is similar to other national COVID-19 household surveillance studies, such as the ONS              
COVD-19 Infection survey​27​, suggesting it is unlikely to be a major source of bias. Individuals               
who gave serum samples were slightly older than those from whom serum was unavailable              
which may result in an over-estimation of the overall population seroprevalence. We relied             
on self-report of presumed COVID-19 illness which may be unreliable. However the timings             
of self reported illness match well to national surveillance data and self-reported illness was              
strongly associated with the presence of anti-spike antibodies suggesting that in this            
population this was a reliable metric.  
 
Although our study was conducted in a strictly Orthodox Jewish community, these            
communities share many characteristics with other ethnic and religious minority groups           
including larger family sizes, increased population density, children attending select schools,           
regular attendance at communal events and gatherings, and English as a second language.             
As such our findings are likely relevant to other tightly-knit ethnic and religious minority              
groups in the UK and elsewhere. Our work, conducted in direct collaboration with the              
community, should be a model for understanding risk in minority populations where there are              
no similar published data currently.  
 
In conclusion, we found evidence for an extremely high rate of SARS-CoV-2 infection in this               
specific community affecting individuals of all ages. This provides further evidence that            
minority communities in the UK and elsewhere are disproportionately affected by the            
COVID-19 pandemic. The reasons for this remain unclear, although are likely to be a              
complex interplay of socio-economic and behavioural factors. Further studies to better           
understand drivers of transmission in ethnic and religious minority populations, conducted           
wherever possible in partnership with communities themselves, are urgently needed to           
reduce health disparities and improve outcomes for these populations.  
 
Supplementary Data 
1. Supplementary Appendix 
2. STROBE Checklist  
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